Cargando…
Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
Due to the positive association between neoadjuvant chemotherapy (NACT) and the promising early response rates of patients with triple negative breast cancer (TNBC), including probabilities of pathological complete response, NACT is increasingly used in TNBC management. Liquid biopsy-based biomarker...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910196/ https://www.ncbi.nlm.nih.gov/pubmed/31789396 http://dx.doi.org/10.3892/ijo.2019.4920 |